Target intelligence / Profile preview

GPI transamidase component PIG-T (PIGT)

Target
PIGT
Molecular classification
Enzyme cofactor/subunit (essential scaffold/regulatory subunit of a multisubunit enzyme complex), Endoplasmic reticulum membrane protein
01

Overview

GPI transamidase component PIG-T (PIGT) is an essential type-I transmembrane protein that forms part of the GPI transamidase enzyme complex in the endoplasmic reticulum. This complex catalyzes the posttranslational attachment of glycosylphosphatidylinositol (GPI) anchors to a wide variety of cell surface proteins, a process required for their proper localization and function. PIG-T specifically stabilizes and maintains the multi-protein complex by associating with other subunits, ensuring correct assembly for GPI anchor transfer. Mutations in the PIGT gene underlie severe congenital disorders affecting blood, nerve, and immune cells, including rare forms of paroxysmal nocturnal hemoglobinuria and congenital disorders of glycosylation. No known drugs directly target this molecule; its essential role is structural and regulatory in protein complex formation rather than being a direct therapeutic target.

Other names
phosphatidylinositol glycan anchor biosynthesis class TGPI-anchor transamidase component PIGTCGI-06PSEC0163UNQ716/PRO1379PIG-TPhosphatidylinositol-glycan biosynthesis class T proteinGPI transamidase subunitneurotrophin-regulated neuronal development-associated proteinMCAHS3NDAPPNH2
02

Biological functions

GPI anchor attachment to proteinsStabilization and assembly of the GPI transamidase complexEnabling the surface expression, transport, and processing of many GPI-anchored proteins
03

Disease associations

Congenital disorders of glycosylation (e.g., PIGT-CDG)Paroxysmal nocturnal hemoglobinuriaNeurodevelopmental and epileptic disorders
04

Safety considerations

Genetic deficiencies and mutations lead to loss of function of GPI anchoring, causing severe developmental, neurologic, and hematologic diseasePathogenic variants can result in blood, immune, and nervous system abnormalities, including hemolysis and recurrent infections

Beyond the preview

Go deeper on GPI transamidase component PIG-T (PIGT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPI transamidase component PIG-T (PIGT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call